Peri-implantitis
Peri-implantitis is characterised by inflammation/ infection around dental implants, and if not treated may lead to implant loss. In 2016, Professor Jamil Shibli (Brazil) participated in a research work to identify the true pathogens related with the etiology of peri-implantitis. Most evidence supporting association of the periodontal ‘red-complex’ pathogens, such as Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia [7]. Professor Jamil Shibli (Brazil) assessed the metabolic activity of blue®m Oral Gel on a subgingival multispecies biofilm compared to chlorhexidine [8]. The results showed an excellent selective effect of blue®m Oral Gel in reducing the account of ‘red
complex’ bacteria as well as inhibiting their ability of biofilm formation. Additionally, the data of many case-report studies showed that blue®m Oral Gel is more effective than regular anti-septic agents in improving the long-term clinical condition of dental implants that had been treated for peri-implantitis with a 3-years follow-up [9]. For example, Dr Ronald Muts (The Netherlands) is always applying blue®m TOOTh protocol for treating cases of peri-implant disease [10].
Oral Lesions
Professor Anna Turkina (Russia) demonstrated the significant improvement and healing in many cases with ulcerative form of Lichen planus after treating them with the use of topical corticosteroids in adjunction with blue®m oxygen therapy [11]. In addition, postoperative pain and the presence of inflammation are common symptoms after oral surgeries. The results of Professor Tatiana Deliberador (Brazil) and co-workers prove the promising effect of blue®m oxygen therapy to reduce any harmful effect on oral tissues, especially during the postsurgical healing phase [12,13]. In cases of large cystic lesions in mandible, blue®m oxygen therapy favors the healing and improving the success of the cases [14].
49
Made with FlippingBook Digital Publishing Software